Piper Sandler Reiterates Overweight on Merit Medical Systems, Raises Price Target to $110
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Jason Bednar has reiterated an Overweight rating on Merit Medical Systems (NASDAQ:MMSI) and increased the price target from $100 to $110.
September 09, 2024 | 2:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler has reiterated an Overweight rating on Merit Medical Systems and increased the price target from $100 to $110, indicating confidence in the company's performance.
The reiteration of an Overweight rating and an increased price target from a reputable analyst suggests a positive outlook for Merit Medical Systems. This is likely to boost investor confidence and potentially lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100